Oppenheimer Asset Management Inc. Purchases 606 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Oppenheimer Asset Management Inc. raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 12.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,459 shares of the company’s stock after acquiring an additional 606 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Henry Schein were worth $350,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in Henry Schein by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock worth $1,165,425,000 after purchasing an additional 260,537 shares during the period. American Century Companies Inc. increased its holdings in shares of Henry Schein by 3.1% in the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock worth $351,543,000 after buying an additional 162,477 shares during the period. Swedbank AB bought a new stake in shares of Henry Schein in the 1st quarter valued at about $215,998,000. Fiduciary Management Inc. WI boosted its holdings in Henry Schein by 17.1% during the 4th quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock valued at $172,947,000 after acquiring an additional 333,855 shares during the period. Finally, Nuance Investments LLC grew its position in Henry Schein by 6.2% during the 2nd quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock worth $119,440,000 after acquiring an additional 108,143 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HSIC. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Evercore ISI cut their price target on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a report on Wednesday, August 7th. UBS Group dropped their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Robert W. Baird reduced their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Finally, Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Friday. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $77.10.

Insider Activity

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

Shares of HSIC stock opened at $71.15 on Friday. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The stock has a market cap of $9.11 billion, a price-to-earnings ratio of 24.04, a PEG ratio of 1.88 and a beta of 0.86. The business’s fifty day moving average is $69.89 and its 200 day moving average is $70.35. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. During the same period last year, the business earned $1.31 EPS. Henry Schein’s quarterly revenue was up .0% compared to the same quarter last year. Research analysts expect that Henry Schein, Inc. will post 4.75 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.